Tower Research Capital (TRC)’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$699K Buy
25,275
+23,733
+1,539% +$657K 0.02% 730
2025
Q1
$34.2K Sell
1,542
-6,941
-82% -$154K ﹤0.01% 2516
2024
Q4
$168K Buy
8,483
+4,575
+117% +$90.5K ﹤0.01% 1835
2024
Q3
$97.7K Buy
+3,908
New +$97.7K ﹤0.01% 2252
2024
Q2
Sell
-758
Closed -$15K 5863
2024
Q1
$15K Sell
758
-9,534
-93% -$188K ﹤0.01% 3273
2023
Q4
$181K Buy
10,292
+9,008
+702% +$158K ﹤0.01% 2186
2023
Q3
$22.3K Sell
1,284
-918
-42% -$15.9K ﹤0.01% 3276
2023
Q2
$31K Sell
2,202
-2,713
-55% -$38.2K ﹤0.01% 2970
2023
Q1
$53K Buy
4,915
+4,001
+438% +$43.1K ﹤0.01% 2437
2022
Q4
$13K Sell
914
-2,163
-70% -$30.8K ﹤0.01% 3616
2022
Q3
$39K Sell
3,077
-1,203
-28% -$15.2K ﹤0.01% 3378
2022
Q2
$42K Buy
4,280
+1,755
+70% +$17.2K ﹤0.01% 3056
2022
Q1
$25K Sell
2,525
-5,459
-68% -$54.1K ﹤0.01% 3325
2021
Q4
$94K Buy
7,984
+3,510
+78% +$41.3K ﹤0.01% 2268
2021
Q3
$50K Sell
4,474
-1,027
-19% -$11.5K ﹤0.01% 2963
2021
Q2
$77K Buy
5,501
+4,167
+312% +$58.3K ﹤0.01% 2642
2021
Q1
$25K Sell
1,334
-1,416
-51% -$26.5K ﹤0.01% 3707
2020
Q4
$49K Sell
2,750
-16,671
-86% -$297K ﹤0.01% 3143
2020
Q3
$298K Buy
19,421
+16,733
+623% +$257K ﹤0.01% 2196
2020
Q2
$68K Buy
2,688
+1,254
+87% +$31.7K ﹤0.01% 2798
2020
Q1
$22K Sell
1,434
-5,380
-79% -$82.5K ﹤0.01% 1668
2019
Q4
$76K Buy
6,814
+6,784
+22,613% +$75.7K 0.01% 1104
2019
Q3
$0 Buy
+30
New ﹤0.01% 4317
2019
Q2
Sell
-498
Closed -$9K 3988
2019
Q1
$9K Buy
+498
New +$9K ﹤0.01% 2736
2018
Q4
Sell
-1,199
Closed -$31K 4105
2018
Q3
$31K Buy
1,199
+969
+421% +$25.1K ﹤0.01% 2053
2018
Q2
$4K Buy
+230
New +$4K ﹤0.01% 3139